Matthew S. Gromisch

Increased Neutrophil-Subset Associated With Severity/Mortality In ARDS And COVID19-ARDS Expresses The Dual Endothelin-1/VEGFsignal-Peptide Receptor (DEspR): An Actionable Therapeutic Target

V. Herrera, B. Levy, J. Goldstein, 2021, Research square.

A targetable ‘rogue’ neutrophil-subset, [CD11b+DEspR+] immunotype, is associated with severity and mortality in acute respiratory distress syndrome (ARDS) and COVID-19-ARDS

V. Herrera, B. Levy, J. Goldstein, 2022, Scientific Reports.

Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model

V. Herrera, M. Grinstaff, F. Carr, 2021, BMC Cancer.

Humanized anti-DEspR IgG4S228P antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis ratnu/nu model

V. Herrera, M. Grinstaff, F. Carr, 2021, BMC cancer.

Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine

Clare Burn Aschner, Matthew S. Gromisch, A. Mahant, 2023, Vaccines.